Clinical trial
A Randomized Placebo Controlled Trial Testing The Effect of Zoledronic Acid on Hip Osteoarthritis
NCT04303026 is registered in ClinicalTrials.gov with Vestre Viken Hospital Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Placebo Controlled Trial Testing The Effect of Zoledronic Acid on Hip Osteoarthritis
- Lead sponsor
- Vestre Viken Hospital Trust
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 2, 2020
- Completion date
- June 30, 2024
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.